Mission Hills Financial Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mission Hills Financial Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.28M	Sell	20,718 -15,598	-43%	-$2.11M	1.44%	17
2026 Q1	$4.64M	Buy	36,316 +414	+1%	+$51.7K	2.37%	16
2025 Q4	$4.38M	Buy	35,902 +61	+0.2%	+$6.99K	2.31%	16
2025 Q3	$3.59M	Buy	35,841 +157	+0.4%	+$14.1K	1.91%	19
2025 Q2	$2.96M	Sell	35,684 -668	-2%	-$53.3K	1.84%	19
2025 Q1	$2.95M	Buy	36,352 +241	+0.7%	+$21.5K	2.05%	18
2024 Q4	$3.25M	Buy	36,111 +4,531	+14%	+$439K	2.52%	16
2024 Q3	$3.25M	Buy	+31,580	New	+$3.1M	2.77%	15

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Mission Hills Financial Advisory's XBI Position: Q2 2026 in Review

Mission Hills Financial Advisory reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 43% in Q2 2026, selling an estimated $2.11M and leaving 20,718 shares worth $3.28M. The position accounts for 1.44% of the portfolio, ranked #17.

Mission Hills Financial Advisory first reported a position in XBI in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.64M in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Mission Hills Financial Advisory held 20,718 shares of State Street SPDR S&P Biotech ETF worth $3.28M as of Q2 2026.
Mission Hills Financial Advisory sold 15,598 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.11M.
State Street SPDR S&P Biotech ETF made up 1.44% of Mission Hills Financial Advisory's portfolio in Q2 2026, its #17 holding.
Mission Hills Financial Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 8 quarters since.
Mission Hills Financial Advisory's State Street SPDR S&P Biotech ETF position peaked at $4.64M in Q1 2026.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Mission Hills Financial Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.